PATENT CLAIM ANALYSIS

Application Number: 16045338
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "445000"]

Abstract:
A composition for transdermal delivery of a progestin for progestin hormone therapy is disclosed. Also disclosed is a transdermal delivery device comprising the composition. For progestin-only hormone therapy, the composition contains an anti-oxidant and does not contain an estrogen. For therapy involving a progestin and an estrogen, the composition contains the progestin, the estrogen and an additional anti-oxidant. Methods of improving the stability of progestin-containing compositions comprising oxidative agents are also disclosed. The methods comprise including one or more anti-oxidants in the compositions.

Claim (Index 6):
The composition of  claim 5  that lacks an estrogen.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 95.0
- Lexical Diversity: 1.91667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13667632', '10621711', '12543859', '12556740', '10130913']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7927685921795746
- 35 USC 102 Novelty (BERT): 0.5482856744319733
- Combined Prediction Score: 0.7683203004048145
- Mean Citation Score: 383.00605
- Max Citation Score: 630.05255
- Similarity Product: 263.0243253220931

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test